- Regulatory information： REACH注册物质：状态：活跃 更新：30-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/25669
- Other safety information： 化学品评估: IMAP评估 - 苯甲酰胺,5-(氨基磺酰基)-N-[(1-乙基-2-吡咯烷基)甲基]-2-甲氧基-: 人类健康I级评估
- Hazard categories and classifications： 急性毒性 4 (14.3%)
- Drug Induced Liver Injury： 参考文献：DOI:10.1016/j.drudis.2019.09.022
- Effects During Pregnancy and Lactation： 一项随机双盲试验研究了60名产后25至40天的女性，其中40名乳汁分泌不足，平均每日293毫升，20名在研究开始时没有乳汁分泌。未提及在研究前后是否对受试者进行任何哺乳教育，也未提及研究期间的哺乳频率。受试者给予左舒必利、右舒必利或消旋舒必利，每日两次50毫克，或安慰剂，持续15天。所有药物组的乳汁产量均增加。所有乳汁分泌不足的女性，包括接受安慰剂的女性，在治疗6天后都可以避免补充喂养。研究开始时没有乳汁分泌且接受药物的女性能够在10至15天后停止补充喂养；安慰剂组的女性在研究结束时无法进行母乳喂养...
Warm reminder：
Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！
Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.
Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！
Research chemical CAS 15676-16-1 HPLC ≥98% 100mg
Research chemical CAS 15676-16-1 HPLC ≥98% 100mg, complete specifications; suitable for production, research, laboratory testing and inspection; digital one-stop procurement platform for scientific materials.
